Three Biotech Stocks To Buy Now: ABBV,BLUE,GILD…Update-2
2/5/16 ...11:20 AM Biotechs Can't Hold Gains ...Drop Back Near 52 Week Lows Hit Wednesday IBB $261 XBI $48 Update-2 At Close 2/4/16...Nice Rally But Off Earlier Highs-Very Stock Specific A nice snap-back rally with a lot of green screen across the board. A tradeable rally but we need...
Large Cap Biopharmaceuticals Winners and Losers 2015-16: Which Stocks Can Outperform the ETFs in 2016?… Part 1
Where is the Growth Potential in Large Cap Biopharmaceutical Companies? Caution: Risk Aversion Remains High Investing in biotech stocks ain't getting easier. The sector is underperforming the market by 16% YTD, sentiment has been burned by concerns about drug pricing and even the spectre of a...
Rayno Dx and Tools: Abbott (ABT) Buys Alere (ALR) For $5.8B Expanding Point-of-Care Diagnostics Platforms
Abbott Laboratories Acquires Alere (ALR) -Stock Soars 45% At Market Opening Alere Product Line Offers Synergies and Boosts Global Diagnostics Presence 2015 Revenues of Alere Are Estimated in $2.5B Range So Deal is About 2.3X Sales Alere (ALR) has a broad-based product line in rapid...
Biotech Stocks Snooze Through Today’s Rally Awaiting Earnings This Week: Large Cap Biopharmaceuticals… ABBV, AMGN, BIIB, BMY, CELG…Update-2
Earnings Updates-2... 1/29 Large Cap Biopharmaceuticals Valuation Models of Large Cap Biotech to be Updated Next Week IBB trying to bottom above $262 down 21.8% YTD Abbvie (ABBV) mixed Q4, maintains 2016 outlook of $4.90-$5.10;Q4 IMBRUVICA of $343M;Merck Hep-C competition coming. ABBV off...
West Coast El Nino Update: Storms Stronger to North and Central Sierras in Heart of California Ski Country..Update-2–High and Dry
2/25/16 El Nino is busted for SoCal. Storms for Central and SoCal pushed out till March 8-10. High pressure blocking pattern for CA. Spring is here in February! 2/13/15 No Major Storms on Horizon-Possible Showers in San Francisco Next Week Look for for major precipitation by end of month but...